Source: BioPharma-Reporter

Purolite: Purolite's launch of innovative DurA Cycle A50 resin, expanding market impact at BIO 2024

At BIO 2024, Purolite made waves in the biopharmaceutical industry with the launch of their innovative DurA Cycle A50 resin.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Steve Brodie's photo - President & CEO of Purolite

President & CEO

Steve Brodie

CEO Approval Rating

70/100

Read more